HCL Systems Convey Superior Glucose Outcomes vs Other Diabetes Technologies
May 11th 2022This new study among a patient population living with type 1 diabetes compared their outcomes according to their type of insulin pump therapy: sensor-augmented pump, predictive low-glucose suspend, and hybrid closed-loop (HCL).
Read More
Video Instruction Just as Effective as In-person for OSA Test, Study Finds
May 11th 2022A randomized, double-blind study found that there was no difference in the recording quality of a home sleep apnea test between patients given in-person instruction vs video instruction, which is an important step in telemedicine diagnosis of obstructive sleep apnea (OSA).
Read More
Study Finds Bimekizumab Well Tolerated Long Term for Moderate to Severe Psoriasis
May 11th 2022Bimekizumab demonstrated a favorable long-term safety profile for the treatment of moderate to severe psoriasis, aside from an increased incidence of mild to moderate oral candidiasis that was also observed with short-term exposure.
Read More
Clostridioides difficile Infection May Be Underdiagnosed in Health Care Facilities, Study Finds
May 11th 2022A study of hospitals and long-term care facilities in Louisville, Kentucky, found low rates of Clostridioides difficile testing in patients with new-onset diarrhea who are frequently infected.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Study Shows Caregivers Prefer Dermatology Specialists Over PCPs for Pediatric Atopic Dermatitis
May 10th 2022Dermatology specialists were cited by diverse caregivers of children with atopic dermatitis (AD) to provide enhanced care delivery and improved AD disease control compared with primary care providers.
Read More
Age, Sex, Socioeconomic Status Play a Role in Likelihood of Consistent RA Treatment, Study Says
May 10th 2022Male sex, older age, lower socioeconomic status, higher comorbidity score, and having an older or male rheumatologist were associated with the reduced likelihood of continuing with rheumatoid arthritis (RA) treatment.
Read More
What's Behind Lagging Payer Uptake of Prescription Digital Therapeutics?
May 10th 2022In a session at the 2022 Asembia Specialty Pharmacy Summit, Jayne Hornung, chief clinical officer at Managed Markets Insights & Technology (MMIT), outlined factors driving payer hesitation when it comes to covering prescription digital therapeutics.
Read More
Taking Action Against the Rising Mental Health Crisis: Efforts From Health Plans, Congress, and More
May 10th 2022Marking Mental Health Awareness month, stakeholders involved in the delivery of behavioral health care services discuss current efforts underway—spearheaded by the novel 988 emergency hotline—to address the growing mental health crisis.
Read More
Pressure-Induced Increase in PD-L1 Expression May Dull Effect of CAR T-Cell Therapy
May 10th 2022The study of constructed αROR1‐CAR T cells showed an increase of PD-L1 expression when exposed to elevated pressure, driving resistance to CAR T cell-mediated cytotoxicity. However, the findings also suggest that adding PD-1/PD-L1 inhibitors to CAR T-cell therapy could help address this.
Read More
Higher Diabetes Risk at Lower Weight, Younger Age for Racial, Ethnic Minorities vs White People
May 9th 2022Black, Asian, and Hispanic adults in the United States were found to have an increased risk for developing diabetes at lower weights and younger ages compared with White Americans, suggesting that screening recommendations for the disease should be altered to reflect this difference.
Read More
EoE Research Examines Long-term Efficacy of PPIs in Responders
May 9th 2022A recent study sought to address what is known about proton pump inhibitors (PPIs) as a therapy for eosinophilic esophagitis and long-term outcomes in patients who respond to them as a way to guide treatment decisions.
Read More
Remote Monitoring Not Successful at Reducing Death, Readmission From HF
May 9th 2022In this study, investigators from Pennsylvania and New York evaluated outcomes among patients following their hospitalization for heart failure (HF) who did or did not participate in a remote monitoring program that included financial incentives for adherence.
Read More
Ribociclib Data Show Reduced Mortality Risk in HR+/HER2- Advanced Breast Cancer
May 9th 2022Officials from Novartis emphasized that the ribociclib-fulvestrant combination is the only one in the CDK4/6 inhibitor class to demonstrate an overall survival benefit when used in a first-line setting among postmenopausal women.
Read More
Review Addresses Antifungal Prophylaxis in AML and Provides Guidance for Novel Agents
May 9th 2022Patients with acute myeloid leukemia (AML) who have undergone intensive chemotherapy are at a very high risk for invasive fungal disease, and a changing treatment landscape warrants further research on drug-drug interactions and outcomes.
Read More
Dr Anna Marzec-Bogusławska: Advocacy Helped to Overcome Fear, Stigma of HIV/AIDS in Poland
May 9th 2022Anna Marzec-Bogusławska, MD, MPH, managing director, National AIDS Center, Warsaw, Poland, discusses how stigma and discrimination permeated the beginning of the HIV/AIDS epidemic the country in the early 1980s and ways that advocates stepped up to overcome peoples’ fears.
Watch